Literature DB >> 15722782

Management of peripheral neuropathic pain.

Brett R Stacey1.   

Abstract

Neuropathic pain results from a variety of medical conditions encountered in physiatric practice, including infection, trauma, metabolic abnormalities, and nerve compression. Unlike pain resulting from nociceptive or inflammatory processes, neuropathic pain is associated with primary lesion or dysfunction of the nervous system itself and is often difficult to treat. Existing treatment options include drug therapy (e.g., anticonvulsants, the lidocaine patch 5%, antidepressants, opioids, tramadol) or interventional treatments (e.g., peripheral or neuraxial nerve blockade, implanted spinal cord stimulators, implanted intrathecal catheters). The following article presents an overview of the cellular mechanisms associated with neuropathic pain, summarizes the results of randomized, controlled trials with the major classes of available drugs, and discusses treatment options that provide a rational basis for pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722782

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  15 in total

1.  Management of painful neuropathies.

Authors:  Harry J Gould
Journal:  Curr Treat Options Neurol       Date:  2007-03       Impact factor: 3.598

Review 2.  Botulinum neurotoxin: evolution from poison, to research tool--onto medicinal therapeutic and future pharmaceutical panacea.

Authors:  Richard M Kostrzewa; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

Review 3.  [Practice-oriented pain therapy in dermatology : Concept with special emphasis on pain quality].

Authors:  P Bialas; W Hubner; T Vogt; T Volk; C S L Müller
Journal:  Hautarzt       Date:  2018-01       Impact factor: 0.751

4.  Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health.

Authors:  Ana Mańas; Juan Pablo Ciria; María Carmen Fernández; María Luisa Gonzálvez; Virginia Morillo; María Pérez; Xavier Masramon; Vanessa López-Gómez
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

Review 5.  [Treatment options in painful diabetic polyneuropathy].

Authors:  Juan J Archelos
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

6.  Sensory innervation of the dorsal longitudinal ligament and the meninges in the lumbar spine of the dog.

Authors:  Barbara Waber-Wenger; Franck Forterre; Kathrin Kuehni-Boghenbor; Renzo Danuser; Jens Volker Stein; Michael Hubert Stoffel
Journal:  Histochem Cell Biol       Date:  2014-04-20       Impact factor: 4.304

Review 7.  Pregabalin for neuropathic pain based on recent clinical trials.

Authors:  Brett R Stacey; Jon N Swift
Journal:  Curr Pain Headache Rep       Date:  2006-06

Review 8.  The Role and Treatment Implications of Peripheral and Central Processing of Pain, Pruritus, and Nausea in Heightened Somatic Awareness: A Review.

Authors:  David R Spiegel; Alexander Pattison; Alexis Lyons; Umer Ansari; Aidan L Mccroskey; Eric Luehrs; Lauren Barr; Stephanie Le
Journal:  Innov Clin Neurosci       Date:  2017-06-01

9.  Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting.

Authors:  Emilio Blanco Tarrio; Rafael Gálvez Mateos; Enric Zamorano Bayarri; Vanessa López Gómez; Maria Pérez Páramo
Journal:  Clin Drug Investig       Date:  2013-09       Impact factor: 2.859

10.  Characteristics of patients with low back and leg pain seeking treatment in primary care: baseline results from the ATLAS cohort study.

Authors:  Kika Konstantinou; Kate M Dunn; Reuben Ogollah; Steven Vogel; Elaine M Hay
Journal:  BMC Musculoskelet Disord       Date:  2015-11-04       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.